| Structural basis for the preferential recognition of immature flaviviruses by a fusion‐loop antibody MV Cherrier, B Kaufmann, GE Nybakken, SM Lok, JT Warren, BR Chen, ... The EMBO journal 28 (20), 3269-3276, 2009 | 241 | 2009 |
| RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor CA Nelson, JT Warren, MWH Wang, SL Teitelbaum, DH Fremont Structure 20 (11), 1971-1982, 2012 | 156 | 2012 |
| IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner CJ DeSelm, Y Takahata, J Warren, JC Chappel, T Khan, X Li, C Liu, ... Journal of cellular biochemistry 113 (9), 2895-2902, 2012 | 113 | 2012 |
| Clonal hematopoiesis and risk for hematologic malignancy JT Warren, DC Link Blood 136 (14), 1599-1605, 2020 | 58 | 2020 |
| Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function JT Warren, W Zou, CE Decker, N Rohatgi, CA Nelson, DH Fremont, ... Journal of cellular biochemistry 116 (11), 2476-2483, 2015 | 47 | 2015 |
| Vinculin Regulates Osteoclast Function T Fukunaga, W Zou, JT Warren, SL Teitelbaum Journal of Biological Chemistry 289 (19), 13554-13564, 2014 | 44 | 2014 |
| Protein-protein docking and analysis reveal that two homologous bacterial adenylyl cyclase toxins interact with calmodulin differently Q Guo, JE Jureller, JT Warren, E Solomaha, J Florián, WJ Tang Journal of Biological Chemistry 283 (35), 23836-23845, 2008 | 36 | 2008 |
| Neuroinflammatory disease as an isolated manifestation of hemophagocytic lymphohistiocytosis A Blincoe, M Heeg, PK Campbell, M Hines, A Khojah, M Klein-Gitelman, ... Journal of Clinical Immunology 40 (6), 901-916, 2020 | 34 | 2020 |
| A 1.3-Å structure of zinc-bound N-terminal domain of calmodulin elucidates potential early ion-binding step JT Warren, Q Guo, WJ Tang Journal of molecular biology 374 (2), 517-527, 2007 | 23 | 2007 |
| Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells HJ Kim, JT Warren, SY Kim, JC Chappel, CJ DeSelm, FP Ross, W Zou, ... Journal of cellular biochemistry 111 (5), 1107-1113, 2010 | 20 | 2010 |
| Heterozygous variants of CLPB are a cause of severe congenital neutropenia JT Warren, RR Cupo, P Wattanasirakul, DH Spencer, AE Locke, ... Blood, The Journal of the American Society of Hematology 139 (5), 779-791, 2022 | 19 | 2022 |
| Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members JT Warren, CA Nelson, CE Decker, W Zou, DH Fremont, SL Teitelbaum Science Signaling 7 (339), ra80-ra80, 2014 | 16 | 2014 |
| Genetics of Inherited thrombocytopenias JT Warren, J Di Paola Blood, 2022 | 6 | 2022 |
| Impaired myelopoiesis in congenital neutropenia: insights into clonal and malignant hematopoiesis JT Warren, DC Link Hematology 2021 (1), 514-520, 2021 | 1 | 2021 |
| Heterozygous mutations of CLPB as a newly identified and frequent cause of severe congenital neutropenia JT Warren, P Wattanasirakul, DH Spencer, A Locke, V Makaryan, ... Blood 134, 433, 2019 | 1 | 2019 |
| 7-Year-Old With a Painful Rash JT Warren, CP Miller, AJ White JAMA pediatrics 170 (8), 801-802, 2016 | 1 | 2016 |
| Spectrum of Pathogenic Genetic Variants in a Large Cohort of North American Congenital and Cyclic Neutropenia Patients: A Report from the Severe Chronic Neutropenia … JT Warren, AA Bolyard, ML Kelley, V Makaryan, DC Dale, DC Link Blood 138, 2059, 2021 | | 2021 |
| Single-chain RANKL Provides Insights into RANK Receptor Oligomerization and a Novel Approach to Osteoclast Inhibition JT Warren Washington University in St. Louis, 2015 | | 2015 |
